Emerald Mutual Fund Advisers Trust’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-823,752	Closed	-$3.87M	–	257
2023 Q2	$3.87M	Sell	823,752 -17,316	-2%	-$79.6K	0.21%	112
2023 Q1	$3.89M	Hold	841,068	–	–	0.23%	109
2022 Q4	$3.05M	Sell	841,068 -1,940	-0.2%	-$8.6K	0.19%	114
2022 Q3	$3.99M	Sell	843,008 -38,050	-4%	-$191K	0.25%	111
2022 Q2	$4.26M	Buy	881,058 +83,628	+10%	+$508K	0.25%	110
2022 Q1	$5.07M	Buy	797,430 +93,207	+13%	+$502K	0.22%	120
2021 Q4	$4.37M	Buy	704,223 +246,113	+54%	+$1.92M	0.15%	132
2021 Q3	$3.96M	Buy	+458,110	New	+$3.74M	0.14%	134

Other funds holding THRN

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's THRN Position: Q3 2023 in Review

Emerald Mutual Fund Advisers Trust sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q3 2023, closing a stake of 823,752 shares — an estimated $3.87M sold.

Emerald Mutual Fund Advisers Trust first reported a position in THRN in Q3 2021 and held it in 8 quarters. The position peaked at $5.07M in Q1 2022. 59 funds tracked by Wall St. Rank hold THRN as of Q3 2023.

Emerald Mutual Fund Advisers Trust reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 823,752 Thorne Healthtech, Inc. Common Stock shares in Q3 2023, an estimated $3.87M.
Emerald Mutual Fund Advisers Trust first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Emerald Mutual Fund Advisers Trust's Thorne Healthtech, Inc. Common Stock position peaked at $5.07M in Q1 2022.
59 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q3 2023.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2023, filed 27 Oct 2023.